{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:59:16Z","timestamp":1794855556801,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disorder characterized by cognitive decline associated with the deposition of amyloid-\u03b2 (A\u03b2) plaques, hyperphosphorylation of tau protein, and neuronal loss. Vascular inflammation and leukocyte trafficking may contribute to AD pathogenesis, and a better understanding of these inflammation mechanisms could therefore facilitate the development of new AD therapies. Here we show that T cells extravasate in the proximity of cerebral VCAM-1<jats:sup>+<\/jats:sup>vessels in 3xTg-AD transgenic mice, which develop both A\u03b2 and tau pathologies. The counter-ligand of VCAM-1 \u2013 \u03b14\u03b21 integrin, also known as very late antigen-4 (VLA-4) \u2013 was more abundant on circulating CD4<jats:sup>+<\/jats:sup>T cells and was also expressed by a significant proportion of blood CD8<jats:sup>+<\/jats:sup>T cells and neutrophils in AD mice. Intravital microscopy of the brain microcirculation revealed that \u03b14 integrins control leukocyte\u2013endothelial interactions in AD mice. Therapeutic targeting of VLA-4 using antibodies that specifically block \u03b14 integrins improved the memory of 3xTg-AD mice compared to an isotype control. These antibodies also reduced neuropathological hallmarks of AD, including microgliosis, A\u03b2 load and tau hyperphosphorylation. Our results demonstrate that \u03b14 integrin-dependent leukocyte trafficking promotes cognitive impairment and AD neuropathology, suggesting that the blockade of \u03b14 integrins may offer a new therapeutic strategy in AD.<\/jats:p>","DOI":"10.1038\/s41598-019-48538-x","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T10:04:06Z","timestamp":1566209046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Blockade of \u03b14 integrins reduces leukocyte\u2013endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Enrica","family":"Pietronigro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zenaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorina Della","family":"Bianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Dusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Terrabuio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Iannoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-2031","authenticated-orcid":false,"given":"Anna","family":"Slanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayehsadat","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekar","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennj","family":"Piacentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Tosadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"48538_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth, H. W. & LaFerla, F. M. Alzheimer\u2019s Disease. N. Engl. J. Med. 362, 329\u2013344 (2010).","journal-title":"N. Engl. J. Med."},{"key":"48538_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1056\/NEJMra040223","volume":"351","author":"JLA\u2019sD Cummings","year":"2004","unstructured":"Cummings, J. L. Alzheimer\u2019s Disease. N. Engl. J. Med. 351, 56\u201367 (2004).","journal-title":"N. Engl. J. Med."},{"key":"48538_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1358\/dof.2017.042.01.2564104","volume":"42","author":"E Zenaro","year":"2017","unstructured":"Zenaro, E. & Constantin, G. Targeting neuroinflammation in the treatment and prevention of Alzheimer\u2019s disease. Drug. Fut. 42, 21 (2017).","journal-title":"Drug. Fut."},{"key":"48538_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro, E., Piacentino, G. & Constantin, G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol. Dis. 107, 41\u201356 (2017).","journal-title":"Neurobiol. Dis."},{"key":"48538_CR5","doi-asserted-by":"crossref","unstructured":"Pietronigro, E. C., Della Bianca, V., Zenaro, E. & Constantin, G. NETosis in Alzheimer\u2019s Disease. Front. Immunol. 8 (2017).","DOI":"10.3389\/fimmu.2017.00211"},{"key":"48538_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","volume":"124","author":"T Togo","year":"2002","unstructured":"Togo, T. et al. Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases. J. Neuroimmunol. 124, 83\u201392 (2002).","journal-title":"J. Neuroimmunol."},{"key":"48538_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro, E. et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21, 880\u2013886 (2015).","journal-title":"Nat. Med."},{"key":"48538_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-3940(88)90690-8","volume":"91","author":"S Itagaki","year":"1988","unstructured":"Itagaki, S., McGeer, P. L. & Akiyama, H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer\u2019s disease brain tissue. Neurosci. Lett. 91, 259\u2013264 (1988).","journal-title":"Neurosci. Lett."},{"key":"48538_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers, J., Luber-Narod, J., Styren, S. D. & Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease. Neurobiol. Aging 9, 339\u2013349 (1988).","journal-title":"Neurobiol. Aging"},{"key":"48538_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/NMM:7:3:255","volume":"7","author":"T Town","year":"2005","unstructured":"Town, T., Tan, J., Flavell, R. A. & Mullan, M. T-Cells in Alzheimer\u2019s Disease. NeuroMolecular Med. 7, 255\u2013264 (2005).","journal-title":"NeuroMolecular Med."},{"key":"48538_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2016.02.009","volume":"54","author":"MT Ferretti","year":"2016","unstructured":"Ferretti, M. T. et al. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer\u2019s disease-like cerebral amyloidosis. Brain Behav. Immun. 54, 211\u2013225 (2016).","journal-title":"Brain Behav. Immun."},{"key":"48538_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000486200","volume":"18","author":"M Merlini","year":"2018","unstructured":"Merlini, M., Kirabali, T., Kulic, L., Nitsch, R. M. & Ferretti, M. T. Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodeg. Dis. 18, 49\u201356 (2018).","journal-title":"Neurodeg. Dis."},{"key":"48538_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1189\/jlb.0710432","volume":"89","author":"B Rossi","year":"2011","unstructured":"Rossi, B., Angiari, S., Zenaro, E., Budui, S. L. & Constantin, G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte\u2013endothelial interactions. J. Leukoc. Biol. 89, 539\u2013556 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"48538_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri3908","volume":"15","author":"D Vestweber","year":"2015","unstructured":"Vestweber, D. How leukocytes cross the vascular endothelium. Nat. Rev. Immunol. 15, 692\u2013704 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"48538_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","volume":"33","author":"B Engelhardt","year":"2012","unstructured":"Engelhardt, B. & Ransohoff, R. M. Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers. Trends Immunol. 33, 579\u2013589 (2012).","journal-title":"Trends Immunol."},{"key":"48538_CR16","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.173.6.1553","volume":"173","author":"BS Bochner","year":"1991","unstructured":"Bochner, B. S. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173, 1553\u20131557 (1991).","journal-title":"J. Exp. Med."},{"key":"48538_CR17","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.4049\/jimmunol.159.8.3929","volume":"159","author":"J Kitayama","year":"1997","unstructured":"Kitayama, J., Fuhlbrigge, R. C., Puri, K. D. & Springer, T. A. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J. Immunol. 159, 3929\u20133939 (1997).","journal-title":"J. Immunol."},{"key":"48538_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0167-5699(99)01544-3","volume":"20","author":"B Johnston","year":"1999","unstructured":"Johnston, B. & Kubes, P. The \u03b14-integrin: an alternative pathway for neutrophil recruitment? Immunol. Today 20, 545\u2013550 (1999).","journal-title":"Immunol. Today"},{"key":"48538_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/01.RES.87.2.153","volume":"87","author":"Y Huo","year":"2000","unstructured":"Huo, Y., Hafezi-Moghadam, A. & Ley, K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 87, 153\u2013159 (2000).","journal-title":"Circ. Res."},{"key":"48538_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"48538_CR21","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1182\/blood-2002-10-3309","volume":"101","author":"L Battistini","year":"2003","unstructured":"Battistini, L. et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 101, 4775\u20134782 (2003).","journal-title":"Blood"},{"key":"48538_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jns.2008.05.020","volume":"272","author":"G Zuliani","year":"2008","unstructured":"Zuliani, G. et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer\u2019s disease or vascular dementia. J. Neurol. Sci. 272, 164\u2013170 (2008).","journal-title":"J. Neurol. Sci."},{"key":"48538_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1160\/TH14-11-0938","volume":"114","author":"CW Huang","year":"2015","unstructured":"Huang, C. W. et al. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer\u2019s dementia. Thromb. Haemost. 114, 1230\u20131240 (2015).","journal-title":"Thromb. Haemost."},{"key":"48538_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"TA Yednock","year":"1992","unstructured":"Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356, 63\u201366 (1992).","journal-title":"Nature"},{"key":"48538_CR25","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","volume":"190","author":"TC Browne","year":"2013","unstructured":"Browne, T. C. et al. IFN-\u03b3 Production by Amyloid -Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer\u2019s Disease. J. Immunol. 190, 2241\u20132251 (2013).","journal-title":"J. Immunol."},{"key":"48538_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2013.07.025","volume":"35","author":"RM McManus","year":"2014","unstructured":"McManus, R. M., Higgins, S. C., Mills, K. H. G. & Lynch, M. A. Respiratory infection promotes T cell infiltration and amyloid-\u03b2 deposition in APP\/PS1 mice. Neurobiol. Aging 35, 109\u2013121 (2014).","journal-title":"Neurobiol. Aging"},{"key":"48538_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2014.08.008","volume":"36","author":"G Lueg","year":"2015","unstructured":"Lueg, G. et al. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer\u2019s disease. Neurobiol. Aging 36, 81\u201389 (2015).","journal-title":"Neurobiol. Aging"},{"key":"48538_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.182.1.604","volume":"182","author":"JM Petty","year":"2009","unstructured":"Petty, J. M., Lenox, C. C., Weiss, D. J., Poynter, M. E. & Suratt, B. T. Crosstalk between CXCR4\/SDF-1 and VLA-4\/VCAM-1 pathways regulates neutrophil retention in the bone marrow. J Immunol 182, 604\u2013612 (2009).","journal-title":"J Immunol"},{"key":"48538_CR29","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1182\/blood-2015-03-631572","volume":"126","author":"S Massena","year":"2015","unstructured":"Massena, S. et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 126, 2016\u20132026 (2015).","journal-title":"Blood"},{"key":"48538_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1096\/fasebj.9.11.7544310","volume":"9","author":"P Kubes","year":"1995","unstructured":"Kubes, P. et al. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J. 9, 1103\u20131111 (1995).","journal-title":"FASEB J."},{"key":"48538_CR31","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.183.5.2175","volume":"183","author":"TB Issekutz","year":"1996","unstructured":"Issekutz, T. B., Miyasaka, M. & Issekutz, A. C. Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J. Exp. Med. 183, 2175\u20132184 (1996).","journal-title":"J. Exp. Med."},{"key":"48538_CR32","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood.V89.10.3837","volume":"89","author":"PH Reinhardt","year":"1997","unstructured":"Reinhardt, P. H., Elliott, J. F. & Kubes, P. Neutrophils Can Adhere Via a4b1 -Integrin Under Flow Conditions. Blood 89, 3837\u20133846 (1997).","journal-title":"Blood"},{"key":"48538_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/86539","volume":"7","author":"GC Ibbotson","year":"2001","unstructured":"Ibbotson, G. C. et al. Functional \u03b14-integrin: A newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat. Med. 7, 465\u2013470 (2001).","journal-title":"Nat. Med."},{"key":"48538_CR34","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.4049\/jimmunol.166.6.4115","volume":"166","author":"S Pereira","year":"2001","unstructured":"Pereira, S., Zhou, M., Mocsai, A. & Lowell, C. Resting Murine Neutrophils Express Functional 4 Integrins that Signal Through Src Family Kinases. J. Immunol. 166, 4115\u20134123 (2001).","journal-title":"J. Immunol."},{"key":"48538_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-014-1355-2","volume":"129","author":"J Neumann","year":"2015","unstructured":"Neumann, J. et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol. 129, 259\u2013277 (2015).","journal-title":"Acta Neuropathol."},{"key":"48538_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","volume":"14","author":"PF Fabene","year":"2008","unstructured":"Fabene, P. F. et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377\u20131383 (2008).","journal-title":"Nat. Med."},{"key":"48538_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12185-010-0555-3","volume":"91","author":"Y Imai","year":"2010","unstructured":"Imai, Y., Shimaoka, M. & Kurokawa, M. Essential roles of VLA-4 in the hematopoietic system. Int. J. Hemato. 91, 569\u2013575 (2010).","journal-title":"Int. J. Hemato."},{"key":"48538_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/nan.12295","volume":"43","author":"FX Lepelletier","year":"2017","unstructured":"Lepelletier, F. X., Mann, D. M. A., Robinson, A. C., Pinteaux, E. & Boutin, H. Early changes in extracellular matrix in Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 43, 167\u2013182 (2017).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"48538_CR39","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1177\/0271678X17722436","volume":"37","author":"MS Thomsen","year":"2017","unstructured":"Thomsen, M. S., Routhe, L. J. & Moos, T. The vascular basement membrane in the healthy and pathological brain. J. of Cereb. Blood Flow Metab. 37, 3300\u20133317 (2017).","journal-title":"J. of Cereb. Blood Flow Metab."},{"key":"48538_CR40","doi-asserted-by":"crossref","unstructured":"St-Amour, I. et al. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation 16 (2019).","DOI":"10.1186\/s12974-018-1380-5"},{"key":"48538_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-54","volume":"11","author":"I St-Amour","year":"2014","unstructured":"St-Amour, I. et al. IVIg protects the 3xTg-AD mouse model of Alzheimer\u2019s disease from memory deficit and A\u03b2 pathology. J Neuroinflammation 11, 54 (2014).","journal-title":"J Neuroinflammation"},{"key":"48538_CR42","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/ni1275","volume":"6","author":"AD Luster","year":"2005","unstructured":"Luster, A. D., Alon, R. & von Andrian, U. H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182\u20131190 (2005).","journal-title":"Nat. Immunol."},{"key":"48538_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1084\/jem.177.1.57","volume":"177","author":"JL Baron","year":"1993","unstructured":"Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G. & Janeway, C. A. Surface Expression of Integrin by CD4 T Cells Is Required for Their Entry into Brain Parenehyma. J. Exp. Med. 177, 57\u201368 (1993).","journal-title":"J. Exp. Med."},{"key":"48538_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1172\/JCI11717","volume":"107","author":"BE Theien","year":"2001","unstructured":"Theien, B. E. et al. Discordant effects of anti\u2013VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J Clin Invest. 107, 995\u20131006 (2001).","journal-title":"J Clin Invest."},{"key":"48538_CR45","doi-asserted-by":"publisher","first-page":"e99068","DOI":"10.1371\/journal.pone.0099068","volume":"9","author":"JE Mindur","year":"2014","unstructured":"Mindur, J. E., Ito, N., Dhib-Jalbut, S. & Ito, K. Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and\/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE. PLoS ONE 9, e99068 (2014).","journal-title":"PLoS ONE"},{"key":"48538_CR46","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2174\/1567205015666180801111033","volume":"15","author":"G Manocha","year":"2018","unstructured":"Manocha, G., Ghatak, A., Puig, K. & Combs, C. Anti-\u03b14\u03b21 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer\u2019s Disease. Curr. Alzheimer Res. 15, 1123\u20131135 (2018).","journal-title":"Curr. Alzheimer Res."},{"key":"48538_CR47","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1084\/jem.194.9.1243","volume":"194","author":"MF Gurish","year":"2001","unstructured":"Gurish, M. F. et al. Intestinal Mast Cell Progenitors Require CD49d\u03b27 (\u03b14\u03b27 Integrin) for Tissue-specific Homing. J. Exp. Med. 194, 1243\u20131252 (2001).","journal-title":"J. Exp. Med."},{"key":"48538_CR48","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/blood-2004-01-0236","volume":"104","author":"Y Mori","year":"2004","unstructured":"Mori, Y. Anti- \u03b14 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. Blood 104, 2149\u20132154 (2004).","journal-title":"Blood"},{"key":"48538_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller, D. H. et al. A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. N. Engl. J. Med. 348, 15\u201323 (2003).","journal-title":"N. Engl. J. Med."},{"key":"48538_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa020732","volume":"348","author":"S Ghosh","year":"2003","unstructured":"Ghosh, S. et al. Natalizumab for Active Crohn\u2019s Disease. N. Engl. J. Med. 348, 24\u201332 (2003).","journal-title":"N. Engl. J. Med."},{"key":"48538_CR51","doi-asserted-by":"publisher","first-page":"e35843","DOI":"10.1371\/journal.pone.0035843","volume":"7","author":"P Iaffaldano","year":"2012","unstructured":"Iaffaldano, P. et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One 7, e35843 (2012).","journal-title":"PLoS One"},{"key":"48538_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-84","volume":"10","author":"S Sotgiu","year":"2010","unstructured":"Sotgiu, S., Murrighile, M. R. & Constantin, G. Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurol. 10, 84 (2010).","journal-title":"BMC Neurol."},{"key":"48538_CR53","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/WCO.0b013e328360279f","volume":"26","author":"K Baldwin","year":"2013","unstructured":"Baldwin, K. & Hogg, J. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis. Curr. Opin. Neurol. 26, 318\u2013323 (2013).","journal-title":"Curr. Opin. Neurol."},{"key":"48538_CR54","doi-asserted-by":"publisher","first-page":"7623823","DOI":"10.1155\/2018\/7623823","volume":"2018","author":"V Durmanova","year":"2018","unstructured":"Durmanova, V. et al. A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 \u03b1 4 Subunit with Increased Risk of Alzheimer\u2019s Disease. Mediators Inflamm. 2018, 7623823 (2018).","journal-title":"Mediators Inflamm."},{"key":"48538_CR55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14712\/fb2015061010008","volume":"61","author":"V \u010eurmanov\u00e1","year":"2015","unstructured":"\u010eurmanov\u00e1, V. et al. VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks. Folia Biol. (Praha) 61, 8\u201313 (2015).","journal-title":"Folia Biol. (Praha)"},{"key":"48538_CR56","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/icb.2012.81","volume":"91","author":"E Zenaro","year":"2013","unstructured":"Zenaro, E., Rossi, B., Angiari, S. & Constantin, G. Use of imaging to study leukocyte trafficking in the central nervous system. Immunol. Cell Biol. 91, 271\u2013280 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"48538_CR57","doi-asserted-by":"crossref","unstructured":"Herr, N., Mauler, M., Bode, C. & Duerschmied, D. Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice. J Vis Exp e53077 (2015).","DOI":"10.3791\/53077"},{"key":"48538_CR58","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.4049\/jimmunol.168.4.1940","volume":"168","author":"L Piccio","year":"2002","unstructured":"Piccio, L. et al. Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors. J. Immunol. 168, 1940\u20131949 (2002).","journal-title":"J. Immunol."},{"key":"48538_CR59","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.176.10.6225","volume":"176","author":"SM Kerfoot","year":"2006","unstructured":"Kerfoot, S. M. et al. Reevaluation of P-Selectin and 4 Integrin as Targets for the Treatment of Experimental Autoimmune Encephalomyelitis. J. Immunol. 176, 6225\u20136234 (2006).","journal-title":"J. Immunol."},{"key":"48538_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","volume":"9","author":"C Dai","year":"2017","unstructured":"Dai, C., Tung, Y. C., Liu, F., Gong, C.-X. & Iqbal, K. Tau passive immunization inhibits not only tau but also A\u03b2 pathology. Alzheimers Res. Ther. 9, 1 (2017).","journal-title":"Alzheimers Res. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48538-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48538-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48538-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:57:49Z","timestamp":1721624269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48538-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48538"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48538-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12055"}}